Related Experiment Video
Updated: Jul 20, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
[Risk-classification in liver cirrhosis]
The Child-Pugh score and Model for End-Stage Liver Disease (MELD) score are common prognostic models for chronic liver disease. This paper compares their characteristics, applications, and limitations to aid clinical decision-making.
Area of Science:
- Hepatology
- Clinical Prognostics
- Medical Statistics
Background:
- Prognostic models are crucial for estimating disease severity and survival in chronic liver disease.
- Commonly used models include the Child-Pugh score and the Model for End-Stage Liver Disease (MELD) score.
- The MELD score, utilizing laboratory values, emerged as a promising alternative to the Child-Pugh score.
Purpose of the Study:
- To summarize and compare the characteristics of the Child-Pugh and MELD scores.
- To evaluate the applications of both prognostic models in chronic liver disease management.
- To identify and discuss the limitations associated with the Child-Pugh and MELD scores.
Main Methods:
- Review and comparison of existing literature on Child-Pugh and MELD scores.
- Analysis of the variables and calculations used in each scoring system.
- Evaluation of the clinical utility and validation studies for both models.
Main Results:
- The Child-Pugh score uses clinical parameters and ascites/encephalopathy grading.
- The MELD score incorporates serum bilirubin, creatinine, and INR for survival prediction.
- Uncertainty remains regarding the definitive replacement of Child-Pugh by MELD.
Conclusions:
- Both Child-Pugh and MELD scores are valuable tools in managing chronic liver disease.
- Understanding their respective strengths and weaknesses is essential for optimal patient care.
- Further research may clarify the ideal role of each score in clinical practice.
Related Concept Videos
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...